chr11-5226613-G-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PM5PP3_StrongPP5_Moderate
The NM_000518.5(HBB):c.279C>A(p.His93Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H93D) has been classified as Likely benign.
Frequency
Consequence
NM_000518.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBB | NM_000518.5 | c.279C>A | p.His93Gln | missense_variant | 2/3 | ENST00000335295.4 | NP_000509.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBB | ENST00000335295.4 | c.279C>A | p.His93Gln | missense_variant | 2/3 | 1 | NM_000518.5 | ENSP00000333994.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 36
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 03, 2019 | The Hb Saint Etienne/Hb Istanbul variant (HBB: [c.279C>A or c.279C>G]; p.His93Gln, also known as His92Gln when numbered from the mature protein, rs34083951), is described in individuals with varying degrees of anemia, as well as in a family presenting with deep vein thrombosis and a strong family history of hemolytic anemia (see link to HbVar and references therein, Aksoy 1972, Au 2009). This variant is also reported in ClinVar (Variation ID: 15208). It is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. Functional characterization of the variant protein indicates reduced hemoglobin stability with increased dissociation into dimers and precipitation in hemolysate (see link to HbVar and references therein, Aksoy 1972), an effect that has also been observed with another variant at this codon (His93Tyr; Bird 1988, Stamatoyannopoulos 1976). Additionally, other variants at this codon (His93Asn, His93Pro) have been described in individuals and families with chronic anemia (Finney 1975, Wajcman 1991). Based on available information, the Hb Saint Etienne/Hb Istanbul variant is considered to be pathogenic. REFERENCES Link to HbVar for Hb Saint Etienne: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=432&.cgifields=histD Aksoy M et al. Hemoglobin Istanbul: substitution of glutamine for histidine in a proximal histidine (F8(92) ). J Clin Invest. 1972 Sep;51(9):2380-7. Au N et al. Two new examples of Hb St. Etienne [beta 92(F8)HisGln] in association with venous thrombosis. Hemoglobin. 2009;33(2):95-100. Bird A et al. Haemoglobin M-Hyde Park associated with polyagglutinable red blood cells in a South African family. Br J Haematol. 1988;68(4):459-64. Finney R et al. Hb Newcastle: beta92 (F8) His replaced by Pro. FEBS Lett. 1975 Dec 15;60(2):435-8. Stamatoyannopoulos G et al. Haemoglobin M Hyde Park occurring as a fresh mutation: diagnostic, structural, and genetic considerations. J Med Genet. 1976;13(2):142-7. Wajcman H et al. Hemoglobin Redondo [beta 92(F8) His----Asn]: an unstable hemoglobin variant associated with heme loss which occurs in two forms. Am J Hematol. 1991 Nov;38(3):194-200. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at